Home » Analyst Articles – US

Union Bankshares (UBSH) Now Covered by Analysts at Boenning Scattergood

Union Bankshares (UBSH) Now Covered by Analysts at Boenning Scattergood

Analysts at Boenning Scattergood initiated coverage on shares of Union Bankshares (NASDAQ:UBSH) in a report issued on Wednesday, The Fly reports. The brokerage set a “neutral” rating on the financial services provider’s... 
Barclays Lowers NorthWestern (NWE) to Underweight

Barclays Lowers NorthWestern (NWE) to Underweight

NorthWestern (NYSE:NWE) was downgraded by Barclays from an “equal weight” rating to an “underweight” rating in a report released on Wednesday, The Fly reports. NWE has been the subject of a number of... 
JPMorgan Chase & Co. Raises Smartsheet (SMAR) Price Target to $45.00

JPMorgan Chase & Co. Raises Smartsheet (SMAR) Price Target to $45.00

Smartsheet (NYSE:SMAR) had its target price increased by JPMorgan Chase & Co. from $33.00 to $45.00 in a research report issued on Wednesday, The Fly reports. The firm presently has an “overweight” rating on... 
Texas Roadhouse (TXRH) Lifted to Overweight at Stephens

Texas Roadhouse (TXRH) Lifted to Overweight at Stephens

Texas Roadhouse (NASDAQ:TXRH) was upgraded by equities researchers at Stephens from an “equal weight” rating to an “overweight” rating in a research note issued on Wednesday, The Fly reports. A number... 
Needham & Company LLC Begins Coverage on Kalvista Pharmaceuticals (KALV)

Needham & Company LLC Begins Coverage on Kalvista Pharmaceuticals (KALV)

Equities researchers at Needham & Company LLC initiated coverage on shares of Kalvista Pharmaceuticals (NASDAQ:KALV) in a research report issued on Wednesday, The Fly reports. The brokerage set a “buy” rating... 
On Track Innovations (OTIV) Stock Rating Lowered by TheStreet

On Track Innovations (OTIV) Stock Rating Lowered by TheStreet

On Track Innovations (NASDAQ:OTIV) was downgraded by TheStreet from a “c-” rating to a “d” rating in a note issued to investors on Monday. Separately, Zacks Investment Research upgraded shares of On Track... 
resTORbio (TORC) Stock Rating Reaffirmed by Wedbush

resTORbio (TORC) Stock Rating Reaffirmed by Wedbush

resTORbio (NASDAQ:TORC)‘s stock had its “outperform” rating reissued by Wedbush in a report issued on Monday. Wedbush also issued estimates for resTORbio’s FY2023 earnings at ($0.05) EPS. TORC has been... 
U.S. Auto Parts Network (PRTS) Downgraded by Zacks Investment Research to “Sell”

U.S. Auto Parts Network (PRTS) Downgraded by Zacks Investment Research to “Sell”

U.S. Auto Parts Network (NASDAQ:PRTS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday. According to Zacks, “US AUTO PARTS NETWORK,... 
LSB Industries (LXU) Upgraded at ValuEngine

LSB Industries (LXU) Upgraded at ValuEngine

ValuEngine upgraded shares of LSB Industries (NYSE:LXU) from a hold rating to a buy rating in a report released on Tuesday morning. Shares of LXU stock opened at $7.04 on Tuesday. The company has a current ratio of 1.32, a quick... 
Energy Transfer LP Unit (ET) Upgraded to Hold by ValuEngine

Energy Transfer LP Unit (ET) Upgraded to Hold by ValuEngine

ValuEngine upgraded shares of Energy Transfer LP Unit (NYSE:ET) from a sell rating to a hold rating in a research report report published on Tuesday morning. Several other research firms have also recently issued reports on... 
Solid Biosciences (SLDB) Upgraded to Buy by ValuEngine

Solid Biosciences (SLDB) Upgraded to Buy by ValuEngine

ValuEngine upgraded shares of Solid Biosciences (NASDAQ:SLDB) from a hold rating to a buy rating in a research note issued to investors on Tuesday. Other analysts have also recently issued research reports about the company.... 
State Street (STT) Downgraded by Zacks Investment Research to Sell

State Street (STT) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research downgraded shares of State Street (NYSE:STT) from a hold rating to a sell rating in a research report report published on Tuesday morning. According to Zacks, “State Street has an impressive... 
Unifi (UFI) Upgraded to “Hold” by Zacks Investment Research

Unifi (UFI) Upgraded to “Hold” by Zacks Investment Research

Zacks Investment Research upgraded shares of Unifi (NYSE:UFI) from a sell rating to a hold rating in a research report report published on Tuesday. According to Zacks, “Unifi, Inc. is a global textile solutions provider... 
NOSTRUM OIL & G/ADR (NSTRY) Downgraded to Strong Sell at Zacks Investment Research

NOSTRUM OIL & G/ADR (NSTRY) Downgraded to Strong Sell at Zacks Investment Research

Zacks Investment Research lowered shares of NOSTRUM OIL & G/ADR (OTCMKTS:NSTRY) from a hold rating to a strong sell rating in a research report released on Tuesday. According to Zacks, “Nostrum Oil & Gas PLC... 
Horiba (HRIBF) Lowered to “Sell” at Zacks Investment Research

Horiba (HRIBF) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of Horiba (OTCMKTS:HRIBF) from a hold rating to a sell rating in a report published on Tuesday. According to Zacks, “Horiba Ltd. engages in manufacture and sale of instruments... 
Obalon Therapeutics (OBLN) Downgraded by Zacks Investment Research to Hold

Obalon Therapeutics (OBLN) Downgraded by Zacks Investment Research to Hold

Obalon Therapeutics (NASDAQ:OBLN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday. According to Zacks, “Obalon Therapeutics, Inc.... 
Dana (DAN) Upgraded by Zacks Investment Research to Buy

Dana (DAN) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Dana (NYSE:DAN) from a hold rating to a buy rating in a research report report published on Tuesday. Zacks Investment Research currently has $21.00 price objective on the auto parts... 
Forterra (FRTA) Cut to Hold at Zacks Investment Research

Forterra (FRTA) Cut to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Forterra (NASDAQ:FRTA) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. According to Zacks, “Forterra, Inc. is a manufacturer of... 
AU Optronics (AUO) Upgraded to Buy at Zacks Investment Research

AU Optronics (AUO) Upgraded to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of AU Optronics (NYSE:AUO) from a hold rating to a buy rating in a research note released on Tuesday morning. Zacks Investment Research currently has $4.25 price target on the semiconductor... 
Bausch Health Companies (BHC) Receives New Coverage from Analysts at SunTrust Banks

Bausch Health Companies (BHC) Receives New Coverage from Analysts at SunTrust Banks

SunTrust Banks assumed coverage on shares of Bausch Health Companies (NYSE:BHC) in a research note released on Tuesday, The Fly reports. The firm issued a buy rating on the stock. Several other equities research analysts have... 
Teva Pharmaceutical Industries (TEVA) Now Covered by Analysts at SunTrust Banks

Teva Pharmaceutical Industries (TEVA) Now Covered by Analysts at SunTrust Banks

SunTrust Banks started coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA) in a report released on Tuesday morning, The Fly reports. The firm issued a hold rating on the stock. TEVA has been the subject of several... 
Smart Sand (SND) Coverage Initiated by Analysts at B. Riley

Smart Sand (SND) Coverage Initiated by Analysts at B. Riley

B. Riley assumed coverage on shares of Smart Sand (NASDAQ:SND) in a report published on Tuesday morning. The firm issued a hold rating and a $5.00 target price on the stock. Separately, Zacks Investment Research upgraded Smart... 
Globus Medical (GMED) Lowered to “Sell” at Zacks Investment Research

Globus Medical (GMED) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of Globus Medical (NYSE:GMED) from a hold rating to a sell rating in a research report released on Tuesday morning. According to Zacks, “Globus Medical, Inc. is a medical device... 
Celsion (CLSN) Given “Buy” Rating at Oppenheimer

Celsion (CLSN) Given “Buy” Rating at Oppenheimer

Oppenheimer reissued their buy rating on shares of Celsion (NASDAQ:CLSN) in a research note issued to investors on Tuesday. A number of other brokerages have also commented on CLSN. Zacks Investment Research upgraded Celsion... 
Cantor Fitzgerald Analysts Give Polarityte (PTE) a $65.00 Price Target

Cantor Fitzgerald Analysts Give Polarityte (PTE) a $65.00 Price Target

Cantor Fitzgerald set a $65.00 price objective on Polarityte (NASDAQ:PTE) in a research report sent to investors on Tuesday morning. The brokerage currently has a buy rating on the stock. Other equities research analysts have... 
CarGurus (CARG) Stock Rating Upgraded by Goldman Sachs Group

CarGurus (CARG) Stock Rating Upgraded by Goldman Sachs Group

CarGurus (NASDAQ:CARG) was upgraded by investment analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Monday, MarketBeat Ratings... 
QAD (QADA) Rating Increased to Buy at Zacks Investment Research

QAD (QADA) Rating Increased to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of QAD (NASDAQ:QADA) from a hold rating to a buy rating in a report published on Saturday morning. They currently have $51.00 price objective on the software maker’s stock. According... 
Audentes Therapeutics (BOLD) Stock Rating Reaffirmed by HC Wainwright

Audentes Therapeutics (BOLD) Stock Rating Reaffirmed by HC Wainwright

Audentes Therapeutics (NASDAQ:BOLD)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a report issued on Monday, The Fly reports. They presently have a $44.00 price target... 
Vapotherm (VAPO) Downgraded to “Sell” at Zacks Investment Research

Vapotherm (VAPO) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of Vapotherm (NYSE:VAPO) from a hold rating to a sell rating in a research note published on Saturday morning. According to Zacks, “Vapotherm Inc. is a medical technology company.... 
WillScot (WSC) Upgraded to Buy at Zacks Investment Research

WillScot (WSC) Upgraded to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of WillScot (NASDAQ:WSC) from a hold rating to a buy rating in a research report released on Saturday. They currently have $12.00 price target on the stock. According to Zacks, “Williams...